Organic & Biomolecular Chemistry · 2015 · 41 citations · 34 references
PharmacyChemistryMedicinal ChemistryDrug DiscoveryOrganic ChemistrySynthetic Medicinal ChemistryAntibacterial AgentsAntibacterial PharmacologyHeterocyclic ChemistryMacrocycle SynthesisMacrocyclic Drug DesignPeptidomimetic DesignComputational Molecular ModelingCyclic Peptide DesignCyclic PeptidomimeticsMacrocycle Library SynthesisMacrocyclic CompoundsMacrocyclic PeptidomimeticsPeptidomimetic Library SynthesisPeptidomimetic Macrocycles
Novel, cyclic peptidomimetics were synthesized by facile acylation reactions using benzotriazole chemistry. Microbiological testing of the synthesized compounds revealed an exceptionally high activity against Candida albicans with a minimum inhibitory concentration (MIC) two orders of magnitude lower than the MIC of the antifungal reference drug amphotericin B. A strikingly high activity was also observed against three Gram-negative bacterial strains (Pseudomonas aeruginosa, Klebsiella pneumoniae and Proteus vulgaris), two of which are known human pathogens. Thus the discovered chemotype is a potential polypharmacological agent. The toxicity against mammalian tumor cells was found to be low, as demonstrated in five different human cell lines (HeLa, cervical; PC-3, prostate; MCF-7, breast; HepG2, liver; and HCT-116, colon). The internal consistency of the experimental data was studied using 3D-pharmacophore and 2D-QSAR.
34
Trygve Brautaset, Olga N. Sekurova, Håvard Sletta et al. · Chemistry & Biology · 2000 · 290 citations · Full text